- Ecabet
-
- $3520.00 / 100mg
-
2025-05-02
- CAS:33159-27-2
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| Product Name: | Ecabet | | Synonyms: | Ecabet;12-Sulfodehydroabietic acid;1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-, (1R,4aS,10aR)-;1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-, [1R-(1α,4aβ,10aα)]-;Abietic acid, dehydro-6-sulfo- (6CI);Podocarpa-8,11,13-trien-15-oic acid, 13-isopropyl-12-sulfo- (8CI);13-Isopropyl-12-sulfopodocarpa-8,11,13-trien-15-oic acid;(1R,4aS,10aR)-7-Isopropyl-1,4a-dimethyl-6-sulfo-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylic acid | | CAS: | 33159-27-2 | | MF: | C20H28O5S | | MW: | 380.5 | | EINECS: | | | Product Categories: | | | Mol File: | 33159-27-2.mol |  |
| | Ecabet Chemical Properties |
| alpha | D25 +72.4° (c = 2.5 in alcohol) | | density | 1.241±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,Room Temperature | | pka | -0.31±0.60(Predicted) |
| | Ecabet Usage And Synthesis |
| Uses | Ecabet sodium (TA-2711) is currently applied to some clinical gastrointestinal disease by inhibiting the ROS production and improving Helicobacter pylori eradication[1]. Ecabet sodium reduces apoptosis[2] | | Definition | ChEBI: Ecabet is a diterpenoid. | | References | [1] Wang Y, et al. Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis. Helicobacter. 2014 Oct;19(5):372-81. DOI:10.1111/hel.12136
[2] Rah YC, et al. Ecabet sodium alleviates neomycin-induced hair cell damage. Free Radic Biol Med. 2015 Dec;89:1176-83. PMID:265617 |
| | Ecabet Preparation Products And Raw materials |
|